Background: Assistive Device plays a significant role for improving elderly people independence and improve their quality of life. the current study Aimed to assess knowledge and attitude of elderly regarding assistive devices and explore barriers that affecting utilization of assistive devices among studied elderly people. Design: A descriptive research design was used in this study. Setting: The study was conducted was conducted at outpatient clinics in Beni-Suef university hospital. Sample: A convenient sample of (86) elderly people was recruited at the current study. Tools: Two tools were used I): A structured interviewing questionnaire which consisted of four parts to assess personal characteristics, medical history, effect of assistive devices on elderly quality of life, and knowledge of elderly people regarding assistive devices II): Scale to measure attitude of the elderly people regarding assistive devices. Results: the present study reveals that 50% of elderly people had ages ranged from 75≥85 yrs., 65.1% of them were male, 26.7% and 38.4% of the studied elderly people had inadequate knowledge and negative attitude respectively regarding assistive device. Conclusion: This study concluded that the majority of elderly people had inadequate knowledge and negative attitude toward the assistive device and a statistically significant relation between elderly people total attitude scores and their age, gender, marital status, and educational level, in addition a highly positive association between elderly people knowledge and attitude regrading assistive device. The study recommended that: Continuing educational programs regarding assistive devices should be provided for the elderly people to improve their knowledge and attitude.
1 July 2019 in NILES journal for Geriatric and Gerontology
Background: Bell's palsy is characterized by partial or complete paralysis of facial muscles. Electromagnetic therapy enhances nerve regeneration and neural growth by inducing modification in the micro-environment around and within the cell, as well as in the cell membrane. Aim: To evaluate the effect of electromagnetic therapy on facial asymmetry in patients with chronic bell's palsy. Materials and Methods: Thirty patients (male and female), with chronic bell's palsy, aged 25 to 45 years participated in the study. They were randomly assigned to two equal groups. Group A (experimental group) received Pulsed Electromagnetic Field Therapy (PEMFT) in addition to standard physical therapy program while group B (control group) received standard physical therapy program. Patients in both groups were evaluated pre-and post-treatment for facial asymmetry using the House-Brackmann (HB) facial nerve grading system and for facial nerve degeneration using electroneurography (ENog). Results: Both groups (group A and group B) showed significant increase on the HB facial nerve grading system and significant decrease in the percentage of facial nerve degeneration. Additionally, there was significant difference in HB facial nerve grading system and percentage of facial nerve degeneration between both groups, post treatment (p=0.001 and p=0.005) respectively. Conclusion: Pulsed Electromagnetic Field Therapy added to standard physical therapy program results in better improvement of facial asymmetry and decreases facial nerve degeneration in in patients with chronic bell's palsy.
Background: Upper extremity (UE) recovery in individuals with subacute stroke often plateaus despite conventional physical therapy (CPT). Smartphone-based virtual reality (VR) represents a low-cost, semi-immersive approach that may enhance task-specific training and neuroplasticity. Objective: To determine whether CPT augmented with smartphone-based VR improves UE function more than CPT alone. Methods: Fifty-seven participants (28 in the experimental group and 29 in the control group) with stroke in the subacute stage (6 weeks–6 months post-stroke) and moderate UE impairment (Fugl-Meyer Assessment–Upper Extremity [FMA-UE] score 20–50) were randomized to receive either CPT plus smartphone-based VR or CPT alone, five sessions per week for six weeks. Outcomes included motor impairment (FMA-UE), activity-level dexterity (Purdue Pegboard Test), and muscle strength (grip strength). Results: Both groups demonstrated significant improvements (p < 0.001). The experimental group showed significantly greater improvements across all outcomes, with large effect sizes. Conclusion: Smartphone-based VR providing semi-immersive, gaze-driven interaction with virtual tasks significantly enhances UE recovery and represents a scalable adjunct to rehabilitation.
Background: Electrical stimulation (ES) is commonly used in stroke rehabilitation to enhance balance and walking, but its effectiveness remains unclear. Purpose: This systematic review evaluated randomized controlled trials (RCTs) on the effects of various ES types including transcranial direct current stimulation (tDCS), functional electrical stimulation (FES), transcutaneous electrical nerve stimulation (TENS), and neuromuscular electrical stimulation (NMES) on balance and gait in stroke patients. Methods: A literature search was conducted in PubMed, Web of Science, and Scopus. RCTs comparing ES with sham or conventional therapies were included. Methodological quality was assessed Via the PEDro scale. Meta analyses were performed for the Berg Balance Scale (BBS), Timed Up and Go (TUG) test and Trunk Impairment Scale (TIS), with qualitative analysis for other outcomes. Results: A meta-analysis of 20 randomized controlled trials (1,366 participants) examined tDCS, FES, TENS, and NMES effects on balance using BBS, TUG, and TIS. Meta-regression analyses within the FES subgroup revealed that stimulation intensity, frequency, and electrode location did not significantly influence treatment outcomes (all P > 0.05). However, outcome type was a significant moderator (QM = 13.59, P = 0.0011), accounting for approximately 56% of between-study heterogeneity. FES showed larger effect sizes for balance outcomes (BBS) compared to mobility (TUG) or trunk control (TIS) measures. Balance improvements were greatest in the acute stroke phase, suggesting that timing may influence ES effectiveness. Conclusion: Electrical stimulation significantly improves balance and trunk control in stroke survivors with consistent effects across studies, however functional mobility benefits remain unclear due to high degree of study variability. Early intervention during acute stroke phases appears most effective, supporting the integration of electrical stimulation into post stroke rehabilitation protocols.
Background: Reduced exercise tolerance, fatigue, and poor sleep negatively affect daily functioning and quality of life. Manual diaphragmatic release (MDR) has demonstrated benefits in respiratory rehabilitation; however, its effects in type 2 diabetes mellitus (T2DM) are unexplored. Objective: This study aimed to examine the impact of a six-week MDR program on exercise capacity, sleep quality, fatigue, and health-related quality of life in older adults with T2DM. Methods: In a single-blind, randomized controlled trial, 44 older adults with type 2 diabetes mellitus (T2DM) were assigned to an experimental group ( n = 22) receiving MDR plus guided breathing exercises or a control group ( n = 22) performing breathing exercises alone. Interventions were conducted three times per week for six weeks. The primary outcomes were exercise capacity (Six-Minute Walk Test, 6MWT) and sleep quality (Pittsburgh Sleep Quality Index, PSQI). The secondary outcomes included Fatigue Assessment Scale (FAS) and quality of life (SF-12). Assessments were performed at baseline and post-intervention. Results: The experimental group showed significantly greater improvement than the control group. The 6MWT distance increased by 24.2 m versus 4.6 m ( P < 0.001, η2 = 0.516). The PSQI and FAS scores decreased significantly ( P = 0.001, η2 = 0.234; P < 0.001, η2 = 0.476), and the quality of life improved ( P < 0.001, η2 = 0.413). Conclusion: A six-week MDR program combined with guided breathing exercises significantly improved exercise capacity, sleep quality, and quality of life and reduces fatigue in older adults with T2DM, supporting MDR as a promising non-pharmacological adjunct for older adults with well-controlled T2DM, with further research needed in broader diabetic populations.
Background and purpose: Upper limb paresis among stroke survivors is the most common physical disability, significantly affecting their ability to perform Activities of Daily Living (ADL). Electrical stimulation is considered a promising approach to restore upper limb function. This study aimed to compare the effectiveness of Sensory Electrical Stimulation (SES) and alternating Electromyogram (EMG) Biofeedback in improving hand function in chronic stroke patients. Materials and Method: Sixty stroke participants were randomly divided into three groups: experimental group 1 received standard physical therapy plus SES; experimental group 2 received physical therapy with alternating EMG Biofeedback; and the control group received only standard physical therapy. Over a three-month period, hand function was evaluated using the Action Research Arm Test (ARAT), muscle strength was assessed via the Medical Research Council (MRC) Scale, and spasticity was measured using the Modified Ashworth Scale. Results: Statistical analysis showed significant improvements in motor function, muscle strength, and reduced spasticity in both experimental groups compared to the control group (p < 0.05). Notably, experimental group 2 (EMG Biofeedback) showed superior outcomes in ARAT subscales—grasp (89.74%), grip (97.62%), and pinch (69.08%)—and exhibited lower wrist spasticity (p = 0.014) than experimental group 1 (SES). Conclusion: The findings suggest that both SES and EMG Biofeedback are effective when integrated into structured hand-training programs for chronic stroke rehabilitation. However, alternating EMG Biofeedback showed greater efficacy in improving hand function, increasing muscular strength, and reducing spasticity, making it a more favorable intervention for this patient population. Trial registration: Registered at ClinicalTrials.gov on 20 th February 2025 (ClinicalTrials.gov identifier: NCT06836596).